Engage Bio
Engage Bio, based in Santa Clara, CA, is a biotech startup in the healthcare industry focusing on developing mRNA-based immunotherapies for cancer treatment.
Company Overview
Engage Bio is a healthcare company based in Santa Clara, CA, USA. The company specializes in therapeutics, operating within the healthcare industry. It was launched in March 2022 and has a current team size of five. Engage Bio participated in Y Combinator's W22 batch and is in its early stages of development. The company's focus is on transforming cancer cells into factories for immunotherapies to defeat cancer.
Innovative mRNA Immunotherapies
Engage Bio is developing mRNA immunotherapies designed to defeat cancer. Their unique approach involves instructing cancer cells to produce and gradually release drugs directly within solid tumors. These mRNA drugs work by inducing cancer cells to express locally acting immunotherapies that engage the immune system to effectively target and combat cancer.
Founders' Background
The founders of Engage Bio bring extensive experience in immunotherapy development, having contributed to the development of four drugs currently in clinical trials. Their expertise in this field underpins the company's innovative approach to cancer treatment, leveraging cutting-edge advancements in synthetic biology and drug discovery.
Active Hiring for Cancer Therapy
Engage Bio is actively expanding its team to support the next generation of cancer therapy. With a focus on pioneering new immunotherapies, the company is looking for talented individuals with a passion for synthetic biology, biotech, healthcare, and drug discovery. Current job openings and updates can be found on the company's LinkedIn page.
Regions Served
Engage Bio primarily serves regions within the United States of America and Canada. The company is committed to advancing healthcare solutions in these areas and is continually working on groundbreaking therapeutic developments to meet the needs of patients facing cancer.